While the biological roles of canonical Wnt/bcatenin signaling in development and disease are well documented, understanding the molecular logic underlying the functionally distinct nuclear transcriptional programs mediating the diverse functions of b-catenin remains a major challenge. Here, we report an unexpected strategy for b-catenin-dependent regulation of celllineage determination based on interactions between b-catenin and a specific homeodomain factor, Prop1, rather than Lef/Tcfs. b-catenin acts as a binary switch to simultaneously activate expression of the critical lineage-determining transcription factor, Pit1, and to repress the gene encoding the lineage-inhibiting transcription factor, Hesx1, acting via TLE/Reptin/ HDAC1 corepressor complexes. The strategy of functionally distinct actions of a homeodomain factor in response to Wnt signaling is suggested to be prototypic of a widely used mechanism for generating diverse cell types from pluripotent precursor cells in response to common signaling pathways during organogenesis.
INTRODUCTION
Among evolutionarily conserved signaling pathways, the pleiotropic effects of Wnt/b-catenin signaling functions are well established in biological processes including embryogenesis, tumorigenesis, and stem cell biology (Cadigan and Nusse, 1997; Dorsky et al., 1998; Hill et al., 2005; Huelsken et al., 2001; Kleber and Sommer, 2004; Lee et al., 2004; Logan and Nusse, 2004; Pinto et al., 2003; Reya et al., 2003; Tao et al., 2005; van de Wetering et al., 2002; Zechner et al., 2003; Murtaugh et al., 2005; Hari et al., 2002) . Activation of the canonical Wnt/b-catenin pathway stabilizes b-catenin protein levels, allowing relocation of b-catenin to the nucleus, where it serves as a coactivator of the Lef/Tcf DNA binding factors, displacing HDAC and TLE corepressor complexes (Behrens et al., 1996; Billin et al., 2000; Cavallo et al., 1998; Daniels and Weis, 2005; Molenaar et al., 1996; van de Wetering et al., 1997) and recruiting coactivators p300/CBP (Hecht et al., 2000) and Brg1 for chromatin remodeling (Barker et al., 2001) . Many proteins are associated with cytoplasmic b-catenin for regulation of Wnt/b-catenin pathway activities (Nelson and Nusse, 2004; Peifer and Polakis, 2000) , but the Lef/Tcf family of transcription factors remain the sole focus as unambiguous DNA binding partners for the diverse b-catenin-dependent nuclear transcription programs (Clevers and van de Wetering, 1997; Giles et al., 2003) . Therefore, understanding whether additional transcriptional strategies are required to achieve the pleiotropic effects of the Wnt/b-catenin signaling pathway remains of major interest.
The development of the anterior pituitary gland provides an ideal model system for investigating signaling functions because it sequentially progresses from a primordium of pluripotent ectodermal cells to a complex organ containing five distinct hormone-producing cell types: corticotropes, lactotropes, somatotropes, thyrotropes, and gonadotropes. Early pituitary development at E9.0-E9.5 requires dorsal-ventral signals such as Sonic hedgehog, Fgf8/10, and Bmp4 and involves the actions of several homeodomain transcription factors expressed before or during the initial invagination of oral ectoderm that creates Rathke's pouch Scully and Rosenfeld, 2002; Watkins-Chow and Camper, 1998) . Later generation of somatotrope, lactotrope, and thyrotrope cell types depends on the function of a tissue-specific POU-class homeodomain transcription factor, Pit1 (Li et al., 1990) . The expression of Pit1 is positively regulated by a paired-like homeodomain transcription factor, Prophet of Pit1 (Prop1) (Gage et al., 1996; Sornson et al., 1996) and negatively regulated by a second, highly related, paired-like factor, Hesx1/Rpx (Hermesz et al., 1996; Martinez-Barbera et al., 2000) , which recruits Groucho/TLE and N-CoR corepressors .
Here, we report a strategy by which the Wnt/b-catenin pathway provides a key signal for determining cell lineages during pituitary development, with direct interactions between b-catenin and the tissue-specific homeodomain factor Prop1, rather than Lef/Tcfs, serving as the mechanism for transcriptional activation of the Pit1 gene. A Prop1/b-catenin complex simultaneously represses expression of the Hesx1 paired-like homeodomain factor via recruitment of TLE/Groucho, HDACs, and Reptin. Together, these results establish a transcriptional switching mechanism for b-catenin control of cell-fate determination based on the actions of Prop1/b-catenin in both gene activation and gene repression.
RESULTS

Temporal Regulation of Wnt/b-Catenin Activity Dictates a Specific Pituitary Cell Lineage
Specific members of the Lef/Tcf transcription-factor family exhibited distinct pituitary-specific expression patterns, with Lef1 reappearing at E13.5 in the anterior gland following initial transient expression at E9.0 ( Figure 1A ). Tcf3 and Tcf4 were expressed during early stages of organ patterning but did not overlap with the initiation of Lef1 and Pit1 expression at E13.5 (see Figure S1A in the Supplemental Data available with this article online), suggesting distinct and nonoverlapping roles with respect to Lef1. Tcf1 expression was negligible in Rathke's pouch. Ten of the nineteen murine Wnt genes were present in the developing E12.5 pituitary by semiquantitative RT-PCR analyses ( Figure S1C ). The Wnt target Axin2 (Aulehla et al., 2003; Jho et al., 2002) was expressed between E11.5 and E15.5 ( Figure 1A ), suggesting a temporally specific function of the Wnt-signaling pathway during pituitary organogenesis. Indeed, chromatin immunoprecipitation on microdissected Rathke's pouches at E12.5 revealed that b-catenin protein was associated with Lef/ Tcf binding regions in the Axin2 promoter (Aulehla et al., 2003; Jho et al., 2002) ( Figure 1B ) and with a Wnt-responsive element conserved in the mouse/human Lef1 promoter (Filali et al., 2002) at E13.5 ( Figure 1B) , providing direct evidence of transcriptional activity of the Wnt/ b-catenin pathway during pituitary development.
We generated two Cre-expressing transgenic lines, Pitx1/Cre and Pit1/Cre, to modulate canonical Wnt/b-catenin signaling-pathway activity by controlling expression of b-catenin using a Cre/LoxP genetic strategy. Crossing with R26R lacZ reporter mice (Soriano, 1999) revealed that the Pitx1/Cre transgene, controlled by the À8 kb Pitx1 promoter Treier et al., 1998) , exhibited efficient Cre-recombinase activity starting at E9.0 in all progenitors of Rathke's pouch that give rise to every cell type of the mature pituitary gland ( Figure 1C , and Figure S1C ), while Pit1/Cre, controlled by the À15 kb Pit1 promoter (Rhodes et al., 1993; Treier et al., 1998) , exhibited efficient Cre-recombinase activity only in the Pit1 lineage starting at E13.5 (data not shown). The Pitx1/Cre and Pit1/Cre transgenic mice were then crossed with conditionally active or inactive b-catenin mouse lines: The bcatenin/loxP(ex2-6) line deletes critical b-catenin coding exons and consequently knocks out the Wnt/b-catenin pathway after Cre-dependent recombination (Brault et al., 2001) , while the b-catenin/loxP(ex3) line generates a stable form of b-catenin protein, thereby leading to a constitutively active Wnt/b-catenin pathway after Cre recombination (Harada et al., 1999) (Figure 1C ). The efficiency of these genetic approaches was verified directly by assaying b-catenin protein levels ( Figure 1C ). The potential roles of b-catenin could then be examined with respect to various transcription factors expressed in temporally specific patterns during pituitary organogenesis ( Figure 1D ).
Following early loss of b-catenin function due to Pitx1/ Cre, the embryos exhibited relatively normal early pituitary development with only subtle morphological defects and a smaller gland along the lateral axis ( Figure 2A) , with unaltered expression of early homeodomain factors Lhx3, Hesx1, Pitx2, Isl1, and Msx1 from E9.5 to E11.5 (Figures 2A-2C and data not shown). Unexpectedly, Pit1 gene (C) Conditional b-catenin alleles for generating tissue-specific constitutively active (CA-Cat) (Harada et al., 1999) and knockout (KO-Cat) (Brault et al., 2001) expression was completely absent in the mutants, based on both in situ hybridization and qPCR analyses, whereas expression of Prop1, an upstream regulator of Pit1, was apparently not altered ( Figure 2B ). Hormone markers for the three Pit1-dependent cell types-somatotropes (GH), thyrotropes (TSHb), and lactotropes (PRL)-were completely absent ( Figures 2C and 2D ) in the E17.5-P0 pituitary gland, consistent with the disappearance of Pit1. The gonadotropes, represented by SF-1, aGSU, and LHb, were still present, although in somewhat reduced numbers ( Figure 2C and 2D and data not shown). The corticotrope/melanotrope lineage, represented by the lineage-determining factor T-Pit/Tbx19 and the hormone POMC, appeared to be increased ( Figure 2C and data not shown). No increased apoptosis was observed from E9.5 to E13.5 (data not shown). These data suggest that b-catenin activity is required for specific cell-lineage determination in the anterior pituitary gland, functioning epistatically to Pit1 activation, potentially in parallel to Prop1.
In contrast to the dramatic consequence of b-catenin deletion with Pitx1/Cre transgenic mice, deletion of b-catenin specifically in the Pit1 lineage starting at E13.5 using Pit1/Cre transgenic mice resulted in apparently normal expression of Pit1 ( Figure 2E ), indicating that maintenance of later Pit1 expression is independent of b-catenin activity. Pituitary cell differentiation was not affected in these mice as determined by expression of POMC, GH, aGSU, and TSHb ( Figure 2E and data not shown). Together, these temporally controlled loss-of-function experiments ( Figure 2 ) demonstrate that b-catenin in the developing pituitary functions specifically to initiate Pit1 gene expression but is not required for the subsequent terminal differentiation events of Pit1 cell types. Indeed, during normal development, expression of Axin2 and Lef1, both indicators of Wnt/b-catenin pathway activity, is diminished after E16.5 ( Figure 1A ).
Lef1/b-Catenin Does Not Induce Pit1 Expression
Consistent with their dependence on the Wnt/b-catenin pathway for expression, neither Lef1 nor Axin2 was detected in the caudomedial (Pit1-positive) field in Pitx1/ Cre early loss-of-function pituitary glands ( Figure 3A ). However, rostral-tip expression of Axin2 persisted in mutants, suggesting that independent mechanisms were responsible for its expression in this region ( Figure 3A and data not shown). Comparison of Pit1 and Lef1 expression using adjacent sections from wild-type embryos revealed that Pit1 became robustly expressed before Lef1 expression commenced. Furthermore, at E14.5, Lef1 expression in the caudomedial domain of the anterior pituitary only partially overlapped the Pit1-expressing cell field ( Figure 3B ), raising questions about any role of Lef1 in regulation of Pit1.
Indeed, in Lef1 gene-deleted mice (van Genderen et al., 1994) , Pit1 gene expression, as well as GH and TSHb gene expression, was not reduced but, if anything, was elevated ( Figures 3C and 3D ). Expression of other Lef/Tcf factors was not altered in Lef1 mutant pituitaries (data not shown). We next examined the presence of Lef1 on the Pit1 gene regulatory regions during development and found that, at E14.5, Lef1 could be detected on the evolutionarily conserved Pit1 early enhancer (EE), located at À8 kb (Sornson et al., 1996) , but not on the late, autoregulatory enhancer (LE) at À10.2 kb. ( Figure 3E ); Tcf4 was not detected, consistent with the fact that it is not expressed at this time point ( Figure S1A ). To investigate whether Lef1 was present on the active or inactive Pit1 gene regulatory sequences, we performed two-step chromatin immunoprecipitation. The first step was performed with anti-Ac K9-H3 IgG and the second step with either anti-Prop1 or anti-Lef1 IgGs ( Figure 3F ). These studies revealed that Prop1, but not Lef1, is present on the activated Pit1 early enhancer, as marked by the presence of acetylated H3K9. (E) ChIP analysis of E14.5 pituitaries, demonstrating that Lef1 is recruited to the Pit1 early enhancer (EE) but Tcf4 is not. (F) Two-step ChIP in GHFT-1 cells with aAcK9H3, followed by either a-Prop1 or aLef1. Prop1 is detected on the active endogenous Pit1 early enhancer, while Lef1 is not recruited.
Thus, the expression of Lef1 actually somewhat attenuates Pit1 gene expression, in contrast to the required actions of b-catenin for inducing Pit1 expression. The Lef1-related factors Tcf3/Tcf4 are poor candidates for compensatory actions with Lef1 in negatively regulating Pit1 because their expression domains are clearly nonoverlapping with Lef1 and Pit1 ( Figure 1A and Figure 3B ; Figure S1A ). More importantly, previous analysis of Tcf4 mutant mice revealed no change in the complement of mature cell types at E18.5 but, instead, an increase in pituitary size apparent at E14.5 (Brinkmeier et al., 2003) . Together, these observations raised the possibility that Wnt/b-catenin might act in a Lef/Tcf-independent manner to achieve Pit1 expression and cell-lineage determination events.
A Prop1/b-Catenin Complex Is Required to Induce Pit1 Expression Therefore, the function of Prop1 in Pit1 gene activation (Sornson et al., 1996) and its potential relationship with the Wnt/b-catenin pathway was investigated. We generated mice in which the Prop1 gene was completely deleted and found that they fully recapitulated the essential features of df (Nasonkin et al., 2004; Sornson et al., 1996) , including loss of Pit1-dependent cell types and dysmorphogenesis of the anterior lobe ( Figure 4A and Figure S2 ). Lef1 was not observed at E13.5 and E14.5 in the Prop1 À/À anterior gland, but it was still expressed in the intermediate lobe ( Figure 4A ). Axin2 remained expressed in the ventral aspect of the lumen and in the anterior lobe of Prop1 À/À pituitaries, indicating that some aspects of Wnt/b-catenin signaling remained intact in the absence of Prop1 ( Figure 4A ).
To investigate potential genetic interactions between Prop1 and b-catenin, we examined double-heterozygous embryos generated by crossing Prop1 +/À mice with conditionally deleted b-catenin heterozygotes and observed a consistently diminished expression of Pit1 in E14.5 double-heterozygote embryos ( Figure 4B ), which provided evidence that b-catenin and Prop1 function in the same genetic pathway to activate Pit1 gene expression. These genetic interactions were further supported by the observation of in vitro physical interactions between these two proteins ( Figure 4C ). The C-terminal 60 aa of Prop1 interacted robustly with the full-length b-catenin protein in a GST pull-down protein-protein interaction assay (Figure 4C ). The homeodomain of Prop1 was capable of weaker interactions with b-catenin ( Figure 4C ). The b-catenin domain was mapped using a series of overlapping fragments, finding that a small region of b-catenin protein consisting of armadillo repeat regions (5-9), corresponding to the Lef/Tcf interaction domain (Graham et al., 2000) , was sufficient to mediate the interactions with Prop1 ( Figure 4C and data not shown). Together, these genetic data demonstrate that b-catenin and Prop1 are both required to regulate Pit1 gene expression. To establish that these interactions between Prop1 and b-catenin holoproteins occur in a cellular context, we performed coimmunoprecipitation in GHFT-1 cells, as demonstrated by a-b-catenin immunoblot of a-FLAG-Prop1 immunoprecipitate ( Figure 4D ). The recruitment of b-catenin to the PrdQ (consensus Prop1 binding) site was analyzed using an avidin-biotin complex DNA binding assay (ABCD) (Glass et al., 1988) . Biotinylated oligos containing 2 PrdQ sites could specifically pull down b-catenin from HeLa cells transfected with FLAG-Prop1 ( Figure 4E ). We found that, in transiently transfected pituitary cell lines in which the b-catenin pathway was stimulated, Prop1 activated the À10 kb Pit1 promoter, which is sufficient for Pit1 gene expression in transgenic mice (DiMattia et al., 1997) ( Figure 4F ). In support of a direct functional relationship between the b-catenin/Prop1 complex and Pit1 gene expression, single-cell nuclear microinjection assays demonstrated the requirement for b-catenin in activation of the early enhancer in the GHFT-1 pituitary cell line, which expresses endogenous Pit1, but not Prop1 (Lew et al., 1993 and data not shown). Prop1 activated the early enhancer, and this activation was specifically blocked by anti-b-catenin IgG or b-catenin siRNA ( Figure 4G and data not shown). As a control for functional specificity, Pit1 actions on a Pit1 response element were b-catenin independent and unaffected by anti-b-catenin IgG or b-catenin siRNA ( Figure 4H and data not shown). Synergistic activation by Prop1 and b-catenin was found using a minimal reporter construct under control of Prop1 regulatory elements (3Â PrdQ) Sornson et al., 1996) in HeLa cells that do not express Prop1. (Figure 4I) . Consistent with the model that b-catenin is a required coactivator for Prop1 ( Figure 4J ), as it is for Lef/Tcf, the transcriptional activity of Prop1/b-catenin complex on a PrdQ reporter was attenuated by overexpression of the b-catenin inhibitors Chibby and ICAT (Tago et al., 2000; Takemaru et al., 2003) . Interestingly, cotransfection of Lef1 with Prop1 and b-catenin expression vectors produced even stronger inhibition of PrdQ reporter activity than Chibby or ICAT ( Figure 4J ). Lef1 was also capable of attenuating Prop1/b-catenin-dependent activation of a À10 kb Pit1 reporter ( Figure 4K) .
While the precise molecular mechanisms by which Lef1 diminishes Prop1/b-catenin-dependent Pit1 gene activation in vivo remain incompletely defined, we have observed in cell culture that excess Lef1 can impair the recruitment of Prop1 to its cognate PrdQ sites in a cotransfection assay followed by chromatin immunoprecipitation and qPCR ( Figure 4L ).
Coordinated Recruitment of Regulatory Complexes to the Pit1 Gene Promoter and Enhancers
Based on the developmental role of Prop1/b-catenin, analyses of factor/cofactor recruitment to regulatory regions of the Pit1 gene (DiMattia et al., 1997; Rhodes et al., 1993) by chromatin immunoprecipitation assay using microdissected embryonic pituitaries were performed. These studies revealed that, at E11.5, the diMe K4-H3, triMeK4-H3, and AcK9-H3 marks of activation were absent, but diMe K9-H3 was present on Pit1 regulatory elements, consistent with an active repression of the Pit1 gene at this time ( Figure 5A and data not shown). At E11.5, the Pit1 early enhancer, which contains Prop1/Hesx1 homeodomain binding sites at À8 kb (Sornson et al., 1996) , was occupied by the Hesx1 repressor and TLE, but Prop1 was not detected. By E12.5, the early enhancer was now occupied by Prop1, with a small residue of TLE1 still detected. However, there was no longer occupancy by Hesx1 at this time, and a diMe K4-H3 mark was selectively present on the early enhancer ( Figure 5B ). By E13.5, the early enhancer and promoter were co-occupied by both Prop1 and b-catenin, with full dismissal of TLEs ( Figure 5C ), coinciding with initial Pit1 gene activation. The diMe K4-H3, triMe K4-H3, and Ac K9-H3 marks associated with active promoters (Kouzarides, 2002) were also present ( Figure 5C and data not shown). In the adult, the Pit1 gene promoter harbored the histone marks of gene activation (triMe K4-H3 and Ac K9-H3), with diMe K4-H3 now present on both the late and early enhancers ( Figure 5D and data not shown). This temporal progression of histone modifications on regulatory regions of the Pit1 gene correlates with the timing of b-catenin transcriptional activity and Prop1 gene expression. Similarly, the loss of Hesx1 and TLE binding from E12.5 to E13.5 tracks the attenuated expression of these factors preceding the induction of the Pit1 gene ).
Wnt/b-Catenin Activity Inhibits Hesx1 Expression
Expression of Pit1 and subsequent differentiation of somatotropes, thyrotropes, and lactotropes also depends on a concurrent attenuated expression of another pairedlike homeodomain transcription factor, Hesx1 . Maintaining transcriptional repression of targets of the Hesx1/TLE complex is important for early pituitary development, and development of the organ can be ablated in Hesx1 À/À embryos in specific genetic backgrounds or when Hesx1-mediated repression is blocked by ectopic expression of Prop1 from the Pitx1 promoter . Examination of the Hesx1 expression pattern in Pitx1/Cre b-catenin gene deleted embryos by in situ hybridization and qPCR revealed that Hesx1 expression persisted in the E14.5 anterior pituitary gland, whereas expression was normally already diminished in the wild-type littermates ( Figure 6A ). Hesx1 expression was similarly extended in the Prop1 mutant embryos (Gage et al., 1996; Sornson et al., 1996 ; data not shown), suggesting the possibility that b-catenin and Prop1 together might subserve the inhibition of Hesx1 expression at E11.5-E13.5. Assessing the effects of premature activation of b-catenin signaling on organ development by generating Pitx1/ Cre:CA-Cat mutants (early gain of function) revealed that, while initial organ commitment was normal at E9.5, there was complete absence of the gland in all mutants examined by E13.5 (12/12) ( Figure 6B ). Lhx3, a marker for the definitive Rathke's pouch that is essential for pituitary development, was initially expressed in the prospective Rathke's pouch at E9.5 in both controls and gainof-function mutants ( Figure 6C ) but was not detected in Rathke's pouch of the b-catenin gain-of-function mutant after E10.5 ( Figure 6D ), a phenotype similar to that observed when Hesx1/TLE repression is absent ). The canonical Wnt/b-catenin target genes Axin2 and Lef1 were upregulated in E9.5 b-catenin gainof-function mutant embryos as expected ( Figure 6E ). Consistent with the model that the Prop1/b-catenin complex negatively regulates Hesx1 expression, we found that Hesx1 was not expressed in E9.5 b-catenin gain-of-function mutants ( Figure 6C) .
A bioinformatic analysis of the mouse and human Hesx1 regulatory sequences revealed several conserved paired-like homeodomain binding sites (Figures 6F-6H ). Prop1 caused repression of reporters containing the conserved regions encompassing the Prop1 binding sites in transient transfection assays ( Figure 6G ). Chromatin immunoprecipitation of E12.5 pituitary glands demonstrated the presence of both b-catenin and Prop1, but not Lef1, on these conserved Hesx1 gene regulatory regions. ChIP also revealed that HDAC1, TLEs, and Reptin were also present with Prop1/b-catenin on the Hesx1 regulatory regions at E12.5 ( Figure 6H ). The functional significance of these putative corepressors was confirmed by use of single-cell nuclear microinjection of specific antibodies ( Figure 6I ) or siRNAs ( Figure 6J ) against b-catenin, HDACs, and TLEs, which reversed the repressive effects of the Prop1/b-catenin complex on the Hesx1 regulatory region. In contrast, aHDAC3 did not reverse repression. Thus, in addition to the role of Prop1/b-catenin in activation of the Pit1 gene, our data suggest that the Prop1/ b-catenin complex simultaneously acts to repress expression of Hesx1 at E12.5 via recruitment of specific corepressor machinery, providing an essential regulatory event required for the progression of normal pituitary development.
DISCUSSION
A Novel DNA Binding Partner for b-Catenin in Cell-Lineage Determination In these studies, we have uncovered a novel transcriptional strategy that underlies b-catenin control of cell-lineage determination in organogenesis, revealing the unexpected role of a tissue-specific homeodomain factor as the essential DNA binding transcription factor that recruits b-catenin in mediating the actions of the Wnt/b-catenin pathway, both for activation and for repression of specific gene targets in pituitary development. In contrast to the common Lef/Tcf factors that are the key DNA binding partners mediating many other aspects of b-catenin activity, here we established genetically and biochemically that b-catenin directly interacts with Prop1 and is a required coregulator for Prop1 transcription activity, causing initial activation of the cell-lineage-determining factor Pit1 at E12.5-E13.5 and simultaneously directing repression of the Hesx1 repressor ( Figure 6K ).
While some aspects of pituitary-gland proliferation are regulated by Wnt4, Wnt5a, Pitx2, Aes1, and Tcf4 (Brinkmeier et al., 2003; Cha et al., 2004; Kioussi et al., 2002; Treier et al., 1998) , our findings suggest that other components of the Wnt signaling pathway serve as key signals for lineage determination events by exerting both positive and negative regulation on tissue-specific homeodomain factors. We find that Wnt/b-catenin signaling occurs in a specific developmental window between E11.5 and E14.5 of pituitary development, where it is required for cell-type determination as cells leave their niche in the lumen of Rathke's pouch. These events reflect a precise contextual requirement for the b-catenin signal; if b-catenin is activated at E9.5, we find that Rathke's pouch is completely destroyed, apparently through perturbations of the endogenous repression program mediated by Hesx1. Conversely, if the b-catenin signal is extended after initial Pit1 lineage determination, terminal cell-type differentiation events within the lineage are inhibited (unpublished data).
Our finding that Prop1 is a key nuclear mediator for Wnt/ b-catenin signaling provides a molecular insight into the mechanism by which Wnt signaling activity dictates celllineage determination. In the skin, for example, b-catenin has proven to be essential for the decision of hair-follicle stem cells to adopt the epithelial or follicular fate (Huelsken et al., 2001) , apparently involving the actions of Lef1 and Tcf3 (Merrill et al., 2001; van Genderen et al., 1994; Zhou et al., 1995) . In contrast to the skin, the nuclear events downstream of Wnt/b-catenin in pituitary cell-lineage determination are not primarily mediated via Tcf/Lef, and our findings suggest that a subset of tissue-restricted homeodomain factors (Kioussi et al., 2002) , and undoubtedly other classes of transcription factors, will prove to play key roles as DNA binding mediators of b-catenin signaling in cell-fate decisions.
Our analyses have also revealed a transcriptional repression function of the Prop1/b-catenin complex, important in mediating cell-lineage determination based on promoter-specific repression of Hesx1. This appears to require a series of corepressors, including HDACs 1/2, Reptin, and Groucho/TLEs. The selective participation of Reptin as a component of b-catenin-mediated repression is supported by its role in repression of Wingless signaling in Drosophila (Bauer et al., 2000) and in suppression of a metastasis suppressor gene in prostate cancer (Kim et al., 2005) .
Thus, investigation of the actions of b-catenin in celllineage determination during pituitary organogenesis has uncovered a simple molecular logic for promoting celllineage determination, significantly differing from the canonical Wnt/b-catenin pathway, based on the key role of b-catenin as the promoter-specific coactivator or corepressor of a tissue-restricted DNA binding transcriptional partner. It is likely that analogous molecular events function broadly in development and disease.
EXPERIMENTAL PROCEDURES
In Situ Hybridization
In situ hybridization was performed as described previously . The antisense in situ probe for Axin2 was a gift from Generation and Analysis of Transgenic Animals and Gene-Targeted Mice Genotype analysis of b-catenin/loxP(ex2-6) and b-catenin/loxP(ex3) mice (Brault et al., 2001; Harada et al., 1999) , Lef1 mutant mice (van Genderen et al., 1994) , and generation of transgenic lines using Pitx1 and Pit1 promoters (Treier et al., 1998) mice, and two controls and four transheterozygotes were processed for analysis. Prop1 mutant mice were generated by targeted mutagenesis in ES cells to replace the entire coding sequence with a b-galactosidase/neomycin selection cassette ( Figure S2 ), and correct targeting was established by Southern blotting with 5 0 and 3 0 external probes.
Transfection and Nuclear Microinjection Assays
Cotransfection experiments were performed as described previously (Rhodes et al., 1993) in 293T and HeLa cells using 750 ng of luciferase reporter, 100 ng of pCMX expression plasmids, and 500 ng of pRSVbGal as an internal control for transfection efficiency. Transfections of pituitary cell lines used Fugene6 (Roche) instead of calcium phosphate. The multimerized PrdQ/p36 luciferase reporter was described previously (Sornson et al., 1996) .
Chromatin Immunoprecipitation
Chromatin immunoprecipitations were performed as previously described (Ju et al., 2004) on microdissected pituitaries, with a modified fixation time of 30 min in 2% paraformaldehyde. Approximately 12 E13.5 pituitaries, 15 E12.5 pituitaries, 25 11.5 pituitaries, or 1 adult pituitary were used for each antibody. Anti-Prop1 antibody was generated in guinea pigs against bacterially expressed C 0 of murine Prop1.
Rabbit anti-Reptin was a generous gift from Otmar Huber (Institute of Clinical Chemistry and Pathobiochemistry, Berlin, Germany). AntidiMeK4H3 and triMeK4H3 were obtained from Upstate Biotechnology, while anti-TLE, anti-Hesx1, anti-HDAC1, and anti-b-catenin were from Santa Cruz Biotechnology. For sequence of ChIP primers, see Supplemental Experimental Procedures.
Coimmunoprecipitation
HeLa cells were transfected with a FLAG-tagged Prop1 expression vector (15 mg/10 cm plate); after 48 hr, the cells were harvested and nuclear extracts were prepared. Five hundred micrograms of nuclear extract was immunoprecipitated with 5 mg of either normal mouse IgG or anti-FLAG antibody (Sigma). The Western blot was carried out with goat anti-b-catenin antibody from Santa Cruz Biotechnology.
GST-Affinity Purification and Protein Interaction Studies
GST-Prop1 homeodomain (amino acids 51-131) and GST-Prop1 C terminus (aa 129-225) fusion proteins for protein interactions were expressed in E. coli and purified from homogenized lysates with glutathione-agarose beads at 25ºC for 1 hr. For interaction studies, immobilized GST-fusion proteins were then mixed with 293T cell lysates containing overexpressed, tagged b-catenin protein or 35 Smethionine labeled b-catenin protein fragments expressed in vitro using reticulocyte lysates (Promega TnT Quick Coupled Transcription/Translation System). Following SDS-PAGE and transfer to nitrocellulose, interacting proteins were visualized by Western blotting or autoradiography. Isotope-labeled b-catenin fragments were N terminus (aa 1-126), C terminus (aa 601-781), Arm repeats 1-4 (aa 121-276), Arm repeats 5-9 (aa 270-483), and Arm repeats 10-12 (aa 477-713).
Avidin-Biotin Complex DNA Binding Assay
The ABCD assay was performed as described (Glass et al., 1988) . See Supplemental Experimental Procedures for details.
Quantitative PCR Real-time PCR was performed on RNA extracted from wild-type and b-catenin knockout embryonic pituitaries at E13.5 (Pit1) and 14.5 (Hesx1). The data were normalized to GAPDH and are presented as fold change with respect to the wild-type. All experiments were performed with two biological and two technical replicates. For oligo sequences, see Supplemental Experimental Procedures. (I and J) Prop1 repression of Hesx1 promoter required b-catenin, Reptin, TLEs, HDAC1, and HDAC2, but not HDAC3, in a single-cell nuclear microinjection assay using specific antibodies (I) and gene-specific siRNAs (J). Data are represented as mean ± SEM.
Supplemental Data
(K) A model for Prop1 homeodomain-mediated nuclear events downstream of Wnt/b-catenin signaling on distinct sets of target genes. In response to a Wnt signal received by pluripotent progenitor cells, stabilized b-catenin acts through direct interactions with the C terminus of Prop1 to activate the Pit1 gene, a lineage-determining factor in pituitary development. Lineage determination is also achieved through the repressive actions of Prop1 and b-catenin, with recruitment of TLE, HDAC, and Reptin corepressors to silence Hesx1, which maintains cellular pluripotence and inhibits cell-fate decisions.
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